Victory Capital Management Inc. Decreases Stock Holdings in SI-BONE, Inc. (NASDAQ:SIBN)

Victory Capital Management Inc. trimmed its holdings in SI-BONE, Inc. (NASDAQ:SIBN) by 0.6% during the third quarter, HoldingsChannel reports. The firm owned 460,338 shares of the company’s stock after selling 2,910 shares during the period. Victory Capital Management Inc.’s holdings in SI-BONE were worth $6,436,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in SIBN. Bellevue Group AG raised its position in shares of SI-BONE by 810.5% during the 1st quarter. Bellevue Group AG now owns 1,139,956 shares of the company’s stock valued at $18,661,000 after buying an additional 1,014,756 shares during the period. Harbor Capital Advisors Inc. raised its position in shares of SI-BONE by 222.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 620,490 shares of the company’s stock valued at $8,674,000 after buying an additional 428,110 shares during the period. American Century Companies Inc. raised its position in shares of SI-BONE by 22.8% during the 2nd quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock valued at $25,685,000 after buying an additional 368,637 shares during the period. Paradigm Capital Management Inc. NY raised its position in shares of SI-BONE by 24.7% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,349,400 shares of the company’s stock valued at $17,448,000 after buying an additional 267,100 shares during the period. Finally, Impax Asset Management Group plc raised its position in shares of SI-BONE by 41.3% during the 3rd quarter. Impax Asset Management Group plc now owns 758,521 shares of the company’s stock valued at $10,604,000 after buying an additional 221,604 shares during the period. Hedge funds and other institutional investors own 98.11% of the company’s stock.

Insiders Place Their Bets

In related news, insider Anthony J. Recupero sold 3,937 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $12.60, for a total transaction of $49,606.20. Following the completion of the transaction, the insider now owns 228,554 shares in the company, valued at approximately $2,879,780.40. The trade was a 1.69 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Anshul Maheshwari sold 2,439 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $12.68, for a total transaction of $30,926.52. Following the transaction, the chief financial officer now owns 194,623 shares of the company’s stock, valued at approximately $2,467,819.64. The trade was a 1.24 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 23,093 shares of company stock worth $299,558 over the last 90 days. Corporate insiders own 3.90% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on SIBN shares. Needham & Company LLC reaffirmed a “buy” rating and set a $19.00 price target on shares of SI-BONE in a research report on Wednesday. Truist Financial lifted their price target on shares of SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, Morgan Stanley dropped their target price on shares of SI-BONE from $21.00 to $19.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $23.00.

SI-BONE Stock Up 2.2 %

SI-BONE stock opened at $12.56 on Friday. SI-BONE, Inc. has a fifty-two week low of $11.70 and a fifty-two week high of $21.70. The company has a debt-to-equity ratio of 0.22, a quick ratio of 7.22 and a current ratio of 8.25. The firm has a 50 day moving average price of $13.72 and a 200 day moving average price of $14.22. The company has a market capitalization of $526.74 million, a PE ratio of -13.65 and a beta of 1.22.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.